92 related articles for article (PubMed ID: 21592572)
1. Focal adhesion kinase as a target in the treatment of hematological malignancies.
Yin B
Leuk Res; 2011 Oct; 35(10):1416-8. PubMed ID: 21592572
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction by focal adhesion kinase in cancer.
Zhao J; Guan JL
Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
[TBL] [Abstract][Full Text] [Related]
4. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
Schwock J; Dhani N; Hedley DW
Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
[TBL] [Abstract][Full Text] [Related]
5. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
[TBL] [Abstract][Full Text] [Related]
6. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
8. Integrin-regulated FAK-Src signaling in normal and cancer cells.
Mitra SK; Schlaepfer DD
Curr Opin Cell Biol; 2006 Oct; 18(5):516-23. PubMed ID: 16919435
[TBL] [Abstract][Full Text] [Related]
9. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
10. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
Kusayama M; Wada K; Nagata M; Ishimoto S; Takahashi H; Yoneda M; Nakajima A; Okura M; Kogo M; Kamisaki Y
Cancer Sci; 2011 Jun; 102(6):1128-36. PubMed ID: 21401805
[TBL] [Abstract][Full Text] [Related]
11. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
[TBL] [Abstract][Full Text] [Related]
12. Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2.
Khare S; Holgren C; Samarel AM
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1100-12. PubMed ID: 16920701
[TBL] [Abstract][Full Text] [Related]
13. An immediate-early protein of white spot syndrome virus modulates the phosphorylation of focal adhesion kinase of shrimp.
Lu H; Ruan L; Xu X
Virology; 2011 Oct; 419(2):84-9. PubMed ID: 21908012
[TBL] [Abstract][Full Text] [Related]
14. Targeting of focal adhesion kinase by small interfering RNAs reduces chondrocyte redifferentiation capacity in alginate beads culture with type II collagen.
Kim YH; Lee JW
J Cell Physiol; 2009 Mar; 218(3):623-30. PubMed ID: 19006177
[TBL] [Abstract][Full Text] [Related]
15. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5.
Salasznyk RM; Klees RF; Boskey A; Plopper GE
J Cell Biochem; 2007 Feb; 100(2):499-514. PubMed ID: 16927379
[TBL] [Abstract][Full Text] [Related]
16. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397.
Hamadi A; Bouali M; Dontenwill M; Stoeckel H; Takeda K; Rondé P
J Cell Sci; 2005 Oct; 118(Pt 19):4415-25. PubMed ID: 16159962
[TBL] [Abstract][Full Text] [Related]
17. Focal Adhesion Kinase as a Potential Target in AML and MDS.
Carter BZ; Mak PY; Wang X; Yang H; Garcia-Manero G; Mak DH; Mu H; Ruvolo VR; Qiu Y; Coombes K; Zhang N; Ragon B; Weaver DT; Pachter JA; Kornblau S; Andreeff M
Mol Cancer Ther; 2017 Jun; 16(6):1133-1144. PubMed ID: 28270436
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
19. Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Lyu A; Humphrey RS; Nam SH; Durham TA; Hu Z; Arasappan D; Horton TM; Ehrlich LIR
Nat Commun; 2023 Oct; 14(1):6270. PubMed ID: 37805579
[TBL] [Abstract][Full Text] [Related]
20. Endosomes: Emerging Platforms for Integrin-Mediated FAK Signalling.
Alanko J; Ivaska J
Trends Cell Biol; 2016 Jun; 26(6):391-398. PubMed ID: 26944773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
